Thomas Horn

Klinikum rechts der Isar

Papers

2

Total Citations

42

H-Index

2

About

Dr. Thomas Horn is a urologic oncologist whose research focuses on improving the diagnosis and surgical management of genitourinary cancers, particularly prostate cancer and upper tract urothelial carcinoma (UTUC). His most impactful work involves pioneering the use of molecular radio-guidance with PSMA-ligands for lymph node dissection in recurrent prostate cancer—a novel technology that enhances surgical precision by enabling real-time detection of metastatic tissue. This contribution, detailed in his most-cited paper (30 citations), represents a significant step forward in targeted salvage surgery. In his work on UTUC, Dr. Horn addresses the critical clinical challenge of discordance between pre-operative biopsy and final pathology, evaluating how this discrepancy affects surgical decision-making and oncologic outcomes. His research identifies key prognostic factors and clarifies the optimal management strategies for this rare but aggressive disease. By bridging the gap between advanced imaging technology and surgical practice, Dr. Horn’s work directly impacts patient care, offering more accurate staging and personalized treatment approaches for men facing recurrent or complex urologic malignancies.

Research Focus

Key Achievements

2
H-Index
2
Papers
42
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Novel technology of molecular radio-guidance for lymph node dissection in recurrent prostate cancer by PSMA-ligands
30 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Klinikum rechts der Isar

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago